Increase of cyclic AMP-dependent protein kinase type II as an early event in hormone-dependent mammary tumor regression.
D015127:9,10-Dimethyl-1,2-benzanthracene; D000818:Animals; D000242:Cyclic AMP / Q000494:pharmacology*; D004789:Enzyme Activation; D004958:Estradiol / Q000494:pharmacology; D005260:Female; D008325:Mammary Neoplasms, Experimental / Q000201:enzymology*; D009365:Neoplasm Regression, Spontaneous; D010766:Phosphorylation; D006656:Protamine Kinase / Q000378:metabolism; D011494:Protein Kinases / Q000378:metabolism*; D051381:Rats
D004958:Estradiol; D015127:9,10-Dimethyl-1,2-benzanthracene; D000242:Cyclic AMP; D011494:Protein Kinases; D006656:Protamine Kinase